112 related articles for article (PubMed ID: 30095901)
1. Concentration-Dependent, Membrane-Selective Activity of Human LL37 Peptides Modified with Collagen Binding Domain Sequences.
Lozeau LD; Youssefian S; Rahbar N; Camesano TA; Rolle MW
Biomacromolecules; 2018 Dec; 19(12):4513-4523. PubMed ID: 30095901
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic predictions of the influence of collagen-binding domain sequences on human LL37 interactions with model lipids using quartz crystal microbalance with dissipation.
Lozeau LD; Rolle MW; Camesano TA
Biointerphases; 2019 Apr; 14(2):021006. PubMed ID: 31039613
[TBL] [Abstract][Full Text] [Related]
3. Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.
Lozeau LD; Grosha J; Kole D; Prifti F; Dominko T; Camesano TA; Rolle MW
Acta Biomater; 2017 Apr; 52():9-20. PubMed ID: 28017866
[TBL] [Abstract][Full Text] [Related]
4. Alginate Affects Bioactivity of Chimeric Collagen-Binding LL37 Antimicrobial Peptides Adsorbed to Collagen-Alginate Wound Dressings.
Lozeau LD; Grosha J; Smith IM; Stewart EJ; Camesano TA; Rolle MW
ACS Biomater Sci Eng; 2020 Jun; 6(6):3398-3410. PubMed ID: 33463166
[TBL] [Abstract][Full Text] [Related]
5. LL37 and collagen-binding domain-mediated LL37 binding with type I collagen: Quantification via QCM-D.
Wei Z; Rolle MW; Camesano TA
Colloids Surf B Biointerfaces; 2022 Dec; 220():112852. PubMed ID: 36179608
[TBL] [Abstract][Full Text] [Related]
6. A QCM-D study of the concentration- and time-dependent interactions of human LL37 with model mammalian lipid bilayers.
Lozeau LD; Rolle MW; Camesano TA
Colloids Surf B Biointerfaces; 2018 Jul; 167():229-238. PubMed ID: 29660601
[TBL] [Abstract][Full Text] [Related]
7. Characterization of LL37 Binding to Collagen through Peptide Modification with a Collagen-Binding Domain.
Wei Z; Rolle MW; Camesano TA
ACS Omega; 2023 Sep; 8(38):35370-35381. PubMed ID: 37779975
[TBL] [Abstract][Full Text] [Related]
8. Atomic Force Microscopy to Characterize Antimicrobial Peptide-Induced Defects in Model Supported Lipid Bilayers.
Swana KW; Nagarajan R; Camesano TA
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576869
[TBL] [Abstract][Full Text] [Related]
9. Differentiating antimicrobial peptides interacting with lipid bilayer: Molecular signatures derived from quartz crystal microbalance with dissipation monitoring.
Wang KF; Nagarajan R; Camesano TA
Biophys Chem; 2015 Jan; 196():53-67. PubMed ID: 25307196
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies.
Ting DSJ; Li J; Verma CS; Goh ETL; Nubile M; Mastropasqua L; Said DG; Beuerman RW; Lakshminarayanan R; Mohammed I; Dua HS
Front Pharmacol; 2021; 12():731499. PubMed ID: 34690770
[No Abstract] [Full Text] [Related]
11. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
12. Arginine-Containing Surfactant-Like Peptides: Interaction with Lipid Membranes and Antimicrobial Activity.
Castelletto V; Barnes RH; Karatzas KA; Edwards-Gayle CJC; Greco F; Hamley IW; Rambo R; Seitsonen J; Ruokolainen J
Biomacromolecules; 2018 Jul; 19(7):2782-2794. PubMed ID: 29738229
[TBL] [Abstract][Full Text] [Related]
13. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
[TBL] [Abstract][Full Text] [Related]
14. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.
Arouri A; Dathe M; Blume A
Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential.
Comune M; Rai A; Chereddy KK; Pinto S; Aday S; Ferreira AF; Zonari A; Blersch J; Cunha R; Rodrigues R; Lerma J; Simões PN; Préat V; Ferreira L
J Control Release; 2017 Sep; 262():58-71. PubMed ID: 28694030
[TBL] [Abstract][Full Text] [Related]
16. Atomistic-Level Investigation of a LL37-Conjugated Gold Nanoparticle By Well-Tempered Metadynamics.
Ferreira AF; Comune M; Rai A; Ferreira L; Simões PN
J Phys Chem B; 2018 Sep; 122(35):8359-8366. PubMed ID: 30106592
[TBL] [Abstract][Full Text] [Related]
17. Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study.
Sherman PJ; Jackway RJ; Gehman JD; Praporski S; McCubbin GA; Mechler A; Martin LL; Separovic F; Bowie JH
Biochemistry; 2009 Dec; 48(50):11892-901. PubMed ID: 19894755
[TBL] [Abstract][Full Text] [Related]
18. Ib-AMP4 insertion causes surface rearrangement in the phospholipid bilayer of biomembranes: Implications from quartz-crystal microbalance with dissipation.
Fan X; Korytowski A; Makky A; Tanaka M; Wink M
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):617-623. PubMed ID: 29106975
[TBL] [Abstract][Full Text] [Related]
19. Multi-biofunction of antimicrobial peptide-immobilized silk fibroin nanofiber membrane: Implications for wound healing.
Song DW; Kim SH; Kim HH; Lee KH; Ki CS; Park YH
Acta Biomater; 2016 Jul; 39():146-155. PubMed ID: 27163404
[TBL] [Abstract][Full Text] [Related]
20. Structure analysis of the membrane-bound dermcidin-derived peptide SSL-25 from human sweat.
Mühlhäuser P; Wadhwani P; Strandberg E; Bürck J; Ulrich AS
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2308-2318. PubMed ID: 28888369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
